Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Sri Lanka
Vladimir Putin
Mahinda Rajapaksa
United States of America
COVID-19
China
Pakistan
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
World

US: FDA grants emergency use approval for Moderna's COVID-19 vaccine

US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
Written by Ramya Patelkhana
Dec 20, 2020, 12:46 am 3 min read
US: FDA grants emergency use approval for Moderna's COVID-19 vaccine
Credits:

The US Food and Drug Administration (FDA) has authorized the COVID-19 vaccine developed by Moderna and the National Institutes of Health for emergency use to ramp up immunization efforts across the world's worst-affected country by the coronavirus pandemic. On Friday, Moderna's vaccine became the second candidate to receive emergency use authorization (EUA) from the US drug regulator after Pfizer earlier this month. Here's more.

Details
Moderna shot 94% effective at preventing the deadly disease

Moderna's vaccine was found to be 94% effective at preventing COVID-19 in clinical trials. With the EUA, it can now be administered to people aged 18 years or older in the US. The US ordered 200 million doses of Moderna's vaccine and the rollout is expected to happen soon. The first vaccine doses will be given to healthcare workers and long-term nursing home residents.

Vaccine
It can protect against severe cases, prevent asymptomatic infections

Moderna's vaccine has been developed using gene-based mRNA technology. It was also found to be effective at protecting against severe cases of COVID-19 as well as preventing asymptomatic infections. On December 11, the FDA granted EUA to Pfizer-BioNTech's COVID-19 vaccine, which is 95% effective against the disease. The Pfizer vaccine is also based on similar gene-based technology.

Storage, distribution
Moderna's less stringent storage requirements compared to Pfizer

Interestingly, Moderna's vaccine is easier to store as compared to the Pfizer-BioNTech vaccine, which is required to be stored at ultra-low temperatures (-70°C to -80°C) until it's ready to be administered. However, Moderna's vaccine can be stored for up to 30 days in a refrigerator between 2°C and 8°C, making it easier to store, which could ease some of the logistical challenges of distribution.

Statement
Delivery of doses to US Government to begin immediately

"The Moderna COVID-19 Vaccine is now authorized for distribution and use under an Emergency Use Authorization (EUA)...Moderna will continue to gather additional data and plans to file a Biologics License Application (BLA) with the FDA requesting full licensure in 2021," said Moderna in a press release. It also said that delivery of the vaccine doses to the US government will commence immediately.

On approval
'Another crucial step in the fight against this global pandemic'

"With the availability of two vaccines now for the prevention of COVID-19, the FDA has taken another crucial step in the fight against this global pandemic that is causing vast numbers of hospitalizations and deaths in the United States each day," stated FDA Commissioner Stephen Hahn. The EUA for Moderna's vaccine came after it was recommended by the FDA's advisory committee of independent experts.

Statement
'We remain focused on scaling up manufacturing: Moderna CEO

"I want to thank the thousands of participants in our clinical trials and the staff at our clinical trial sites...I am proud of what the Moderna team has achieved in collaboration with our partners," stated Moderna CEO, Stephane Bancel. "We remain focused on scaling up manufacturing to help us protect as many people as we can from this terrible disease," he added.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Ramya Patelkhana
Ramya Patelkhana
Mail
Ramya Patelkhana is a senior editor at NewsBytes. She has nearly seven years of experience in digital journalism and has previously worked with India News and Authint Media. She has a Bachelor's degree in Journalism and Mass Communication from the IK Gujral Punjab Technical University, Kapurthala, and an advanced diploma in Media Studies from IPW, New Delhi.
Latest
Related
Latest
Char Dham Yatra: Health screening amid pilgrim deaths; details here
Char Dham Yatra: Health screening amid pilgrim deaths; details here India
BAN vs SL, 1st Test: Mathews' 199 headlines Day 2
BAN vs SL, 1st Test: Mathews' 199 headlines Day 2 Sports
Teaser of Nayanthara's 'O2' dropped; film premiering on Disney+ Hotstar
Teaser of Nayanthara's 'O2' dropped; film premiering on Disney+ Hotstar Entertainment
IPL 2022, PBKS vs DC: Mayank Agarwal elects to field
IPL 2022, PBKS vs DC: Mayank Agarwal elects to field Sports
Meet 'Jug Jugg Jeeyo' family: Cast introduces their wholesome characters
Meet 'Jug Jugg Jeeyo' family: Cast introduces their wholesome characters Entertainment
Related
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds
European drug regulator approves Moderna COVID-19 vaccine, Spikevax, for 12-17-year-olds World
Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass'
Seven EU nations, Switzerland approve India-made Covishield for 'Green Pass' World
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022